Literature DB >> 30293014

Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia.

Emilio Sacchetti1, Paolo Valsecchi2, Elena Tamussi3, Laura Paulli2, Raffaele Morigi2, Antonio Vita2.   

Abstract

The aims of this study were to establish the prevalence of moderate and severe psychomotor agitation in patients hospitalized for an active phase of schizophrenia, the associations between psychomotor agitation and patients' demographic and clinical variables, the intra-individual stability of the agitated/non-agitated dichotomy in independent psychotic breakdowns. The study was performed on a database relative to 630 inpatients hospitalized with a diagnosis of schizophrenia. Psychomotor agitation was measured with the Positive and Negative Syndrome Scale - Excited Component (PANSS-EC). Prevalence of moderate and severe psychomotor agitation was 40.5% and 23.7%, respectively. Non-agitated patients were older, with longer illness history and duration of untreated psychosis, were more frequently on antipsychotic medication, had lower incidence of recent use of substances, and functioned better before the index hospitalization than moderately and/or severely agitated patients. Non-agitated patients had lower scores for total PANSS and Emsley's positive and anxiety dimensions. Compared with the severely agitated group, non-agitated and moderately agitated patients scored more in Emsley's depression dimension. Poor functioning before index hospital admission, higher scores for negative subscale and Emsley's positive dimension and use of substances exerted an effect on risk of psychomotor agitation.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30293014     DOI: 10.1016/j.psychres.2018.09.058

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Distribution of agitation and related symptoms among hospitalized patients using a scalable natural language processing method.

Authors:  Kamber L Hart; Amelia M Pellegrini; Brent P Forester; Sabina Berretta; Shawn N Murphy; Roy H Perlis; Thomas H McCoy
Journal:  Gen Hosp Psychiatry       Date:  2020-11-10       Impact factor: 3.238

2.  Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics.

Authors:  Stefano Barlati; Gabriele Nibbio; Donato Morena; Paolo Cacciani; Paola Corsini; Alessandra Mosca; Giacomo Deste; Vivian Accardo; Valentina Regina; Jacopo Lisoni; Cesare Turrina; Paolo Valsecchi; Antonio Vita
Journal:  Front Psychiatry       Date:  2022-03-30       Impact factor: 4.157

3.  Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed.

Authors:  Leslie Citrome; Robert Risinger; Lavanya Rajachandran; Heather Robison
Journal:  Adv Ther       Date:  2022-08-24       Impact factor: 4.070

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.